- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Mesalazine – November 2015
Mesalazine: Modified released, 1.2 g tablet, 60, Mezavant®
Last updated
4 March 2016